Top Human Genetics Meet 2025, Immunogenetic Summit, Genetic Diseases, Gene Therapy, London, UK, Asia Pacific, Europe

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Europe & UK

Stem Cell 2025, Germany cellscience-cs-2025, Spain Human Genetics 2025, Spain Genome 2025, Spain

Asia Pacific & Middle East

Canada

HUMAN GENETICS MEET 2025

Welcome Message

We are delighted to welcome you to the 13^th World Congress on Human Genetics and Genetic Diseases, scheduled for June 12-13, 2025 in London, UK.. This year's event features the cutting-edge theme "Innovations in Drug Development for Human Genetic Conditions" aimed at introducing new ideas, techniques, and strategies that promise to transform your professional practices. Our conference brings together top experts in the field of HUMAN GENETICS MEET 2025.

The conference provides a premier platform for distinguished researchers, experts, university professors, geneticists, and students. The event features a comprehensive program with lectures, presentations from geneticists, poster sessions, and discussions, all designed to facilitate extensive knowledge exchange. It is an excellent opportunity to share your research experiences and gain recognition through certificates endorsed by our esteemed organizing committee.

No other event offers the exceptional line up of keynote speakers, distinguished participants, and engaging content that we provide. This is a prime opportunity for academics from universities and institutes to network with fellow scholars. If you’re interested, confirm your participation by joining the conference with your colleagues.

About Conference

The Conference Series is pleased to invite geneticists, professors, doctors, students worldwide to attend the "13^th World Congress on Human Genetics and Genetic Diseases". This outstanding event will focus on the theme "Innovations in Drug Development for Human Genetic Conditions" scheduled for June 12-13,2025 in London, UK.

HUMAN GENETICS MEET 2025 provides a unified platform for international medical and health professionals to gather, share, and discuss research findings in Human Genetics and Diseases. This conference offers a global stage for exploring ground breaking innovations and engaging with scientists, researchers, practitioners, emerging sac, and industry experts from around the world.

The HUMAN GENETICS MEET 2025 conferences are dedicated to showcasing the latest advancements in Human Genetics and Diseases research, offering new perspectives on genes, genetic diseases and gene therapy. The “Human Genetics and Genetic Diseases Conferences” aim to illuminate the latest advancements in genetic research and its applications to genetic disorders. These conferences offer a premier platform for networking with leading experts, researchers, and practitioners from around the world. Featuring internationally renowned speakers, innovative methodologies, and the latest developments in genetic technologies, the event stands out for its comprehensive exploration of human genetics and genetic diseases. Through a series of conferences, symposia, and workshops, this forum fosters the advancement, critical evaluation, and exchange of cutting-edge knowledge in the field.

Why Attend?

Engage with Leading Experts: Connect with esteemed scholars, researchers, and professionals from various branches of Genetics and Genomic Medicine.

Diverse Sessions: Participate in oral and poster presentations, workshops, symposiums, and keynote sessions delivered by world-renowned speakers.

Awards & Recognition: Celebrate excellence with awards distributed across multiple categories.

Interactive Experiences: Explore cutting-edge research and innovations through exhibitions and interactive sessions.

Our conference aims to provide a comprehensive platform for knowledge sharing and collaboration. With contributions from distinguished speakers, delegates, and editorial board members from reputed journals, we are committed to making this event a success.

Join us for an enriching experience in London, where scientific advancement meets.

TARGET AUDIENCE
Geneticists
Molecular Biologists
Biomedical Researchers
Genetic Counsellors
Clinical Geneticist
Paediatricians
Obstetricians
Pharmacogenomics Experts
Bioinformaticians
Public Health Professionals
Academics and Educator
Pharmaceutical Industry Representatives
Biotech Industry Professionals
Regulatory and Policy Makers
Nurses and Physician Assistants
Patient Advocacy Groups
Ethicists
Legal Experts
Students and Early-Career Researchers
Health Economists

FOR ABSTRACT

Length: Abstracts should not exceed 300 words.
Title: Use sentence case for the title.
Author Information: Include the full names of all authors and co-authors, along with their affiliations.
Biography and Photo: Provide a brief author biography (up to 100 words) and a photograph.
Evaluation: All abstracts will be reviewed by the scientific committee, with feedback sent via email within 24-48 hours of submission.
Publication: Accepted abstracts will be published in the conference proceedings in the relevant journal.

This is the link for abstract submission: https://humangenetics.geneticconferences.com/abstract-submission.php

We welcome speakers from across the globe to submit their abstracts, research papers, case studies, and posters in alignment with the "Call for Abstracts" or their specific areas of research interest.

For attendees, including doctors, presenters, physicians, students, academicians, sponsors, exhibitors and groups, “HUMAN GENETICS MEET 2025” offers cost-effective registration options, as well as special group registration for webinars.

You can register for the conference by visiting the registration page:

https://humangenetics.geneticconferences.com/registration.php

Sessions/ Tracks

SESSIONS/TRACKS

1. Classical Genetics: Classical genetics focuses primarily on the observable traits resulting from genetic inheritance. The field is rooted in the experiments conducted by Gregor Mendel, whose work established the foundational principles of heredity. Classical genetics remains significant for its role in understanding and applying the fundamental mechanisms of inheritance.

Allele
Phenotype
Genomics
Linkage Maps
Mutation

2. Immunogenetics: Immunogenetics examines the complex relationship between genetics and the immune system, encompassing both medical genetics and immunology. It is crucial for understanding genetic predispositions to autoimmune diseases, such as Type 1 diabetes, which arise from immune system dysfunctions. This area of study focuses on several key aspects, including:

Intraspecific Heterogeneity
Tissue Receptor Inheritance
Host-Microbe Interactions
Tissue Incompatibility
Major Histocompatibility Complex (MHC)
Human Leukocyte Antigen (HLA)
Vaccine Efficacy
Mono-specific Antibody

3. Phylogenetic: Phylogenetic is a powerful approach used to trace the evolutionary history and relationships among modern species. By analysing phylogenetic trees, scientists can uncover the similarities and differences between species and gain insights into their evolutionary development. This method is widely applied across various fields, including:

Forensic Science
Conservation Biology
Epidemiology
Drug Discovery and Design
Protein Structure and Function Prediction
Gene Function Prediction

4. Comparative Genomics: Comparative genomics involves the direct comparison of the complete genetic makeup of different organisms to gain insights into how species have evolved and to uncover the functions of genes and noncoding regions within genomes. By analysing and comparing genome sequences across various species, comparative genomics enhances our understanding of genome evolution and the impact of natural selection on DNA sequence changes.

Easyfig
Ensembl
Kegg (Kyoto Encyclopaedia of Genes and Genomes)

5. Clinical Genetics: Clinical genetics provides genetic counselling and diagnostic services for individuals or families affected by or at risk of genetic disorders. These conditions can impact any body system and manifest at any age. The primary objective of clinical genetics is to support individuals with genetic disorders or those at risk, helping them live healthy lives and make informed decisions about their reproductive options.

Genetic Counselling
Genetic Diagnosis
Personalized Management Plans
Reproductive Planning
Cross-Disciplinary Collaboration

6. Gene Function Prediction & Genome Annotation: Gene Function Prediction and Genome Annotation are critical components of genomics that involve identifying and characterizing genes and their functions within a genome. These processes are essential for understanding biological systems, disease mechanisms, and evolutionary relationships.

Geneid
Jigsaw
Augustus
EuGene

7. Genome Integrity: The Genome Integrity Unit is dedicated to studying the mechanisms that maintain the health and stability of DNA, with a particular emphasis on cancer and early development. This unit investigates how cells preserve genomic integrity through sophisticated DNA repair processes in response to damage.

8. Genetic Epidemiology: Genetic Epidemiology is a specialized field that merges concepts and methods from epidemiology with insights from population and quantitative genetics. It seeks to elucidate how genetic and environmental factors interact to influence disease occurrence and progression within populations. As a relatively recent area of study, genetic epidemiology focuses on understanding the complex interplay between genes and environment in the aetiology of diseases.

Interaction Analysis
Population-Level Insights
Risk Assessment

9. Common Genetic Diseases: Genetic diseases, prevalent across diverse populations worldwide, often arise from specific genetic mutations or chromosomal abnormalities. Despite varying geographical locations and cultural backgrounds, certain genetic disorders are notably common due to their underlying genetic causes. Ongoing research and advances continue to enhance our understanding and management of these conditions.

Down Syndrome (Trisomy 21)
Fragile X Syndrome
Klinefelter Syndrome
Triple-X Syndrome
Turner Syndrome
Trisomy 18 (Edwards Syndrome)
Trisomy 13 (Patau Syndrome)

10. Lethal Genetic Diseases: Lethal genetic diseases are caused by mutations in essential genes that can lead to the death of the affected organism. These mutations often disrupt critical processes required for development or growth. Lethal alleles can be classified as recessive, dominant, or conditional, depending on their genetic behaviour. They may cause death either before or shortly after birth, but typically manifest early in development.

Cystic Fibrosis
Sickle-Cell Anaemia
Achondroplasia

11. Nutrigenetics & Nutrigenomics: Nutrigenetics and Nutrigenomics are interrelated fields that explore the complex interactions between nutrition, genetics, and health. These disciplines enhance our understanding of how dietary components influence genetic expression and metabolic processes, ultimately impacting disease risk and overall health.

Metabolic Pathways
Food Components
Gene-Diet Interactions

12. Cancer Genetics: Cancer genetics is a scientific field dedicated to uncovering the genes and metabolic processes that drive cancer development. This area of study explores:

Metabolic Pathways
Tumour Networks and Pathways
Gene Interactions

13. Gene Therapy: Gene therapy is an innovative medical approach aimed at treating or preventing diseases by addressing their underlying genetic causes. Unlike conventional treatments that rely on drugs or surgery, gene therapy directly alters a patient's genetic material to correct or compensate for faulty genes. This method holds the potential to offer long-term or even permanent solutions to various genetic disorders.

Ex Vivo Gene Therapy
In Vivo Gene Therapy
In Situ Gene Therapy
Germline Therapy
Somatic Gene Therapy

14. Neurogenetics: Neurogenetics examines the influence of genetic factors on the development and function of the nervous system, highlighting how hereditary variations impact neurological traits and disorders. This interdisciplinary field integrates insights from both genetics and neurology, focusing on how genetic variations can manifest in neural features and affect an individual's neurological health, behaviour, and personality. By studying these genetic influences, neurogenetics aims to enhance our understanding of both typical and atypical nervous system function, contributing to the comprehension of genetic foundations underlying neurological conditions.

Clinical Exome Sequencing
Transgenic RNAi

15. Pharmacogenomics: Pharmacogenomics is also known as pharmacogenetics or drug-gene testing which is the study of how an individual’s genetic makeup affects their response to medications. This field aims to personalize drug therapy to optimize treatment outcomes and minimize adverse effects, ultimately enhancing the efficacy and safety of pharmaceuticals.

Personalized Medicine
Reducing Adverse Drug Reactions
Improving Healthcare Efficiency

16. Genetics of Cardiovascular Diseases: Inherited cardiac conditions (ICCs) also known as genetic cardiac conditions, encompass a range of relatively rare heart diseases caused by mutations in one or more genes. These genetic abnormalities can lead to various heart issues, including:

Structural Heart Changes: Genetic mutations that affect the structure of the heart muscle, potentially leading to symptoms of heart failure.
Electrical System Disruptions: Abnormalities in genes that impact the heart’s electrical system, which can result in irregular cardiac rhythms.

17. Population Genetics: Population genetics is the branch of genetics focused on understanding genetic variation within and between populations and the evolutionary processes driving these variations. It explores how genetic diversity is distributed and maintained over time, relying on the Hardy-Weinberg equilibrium as a foundational principle. This equilibrium assumes a large population size, random mating, and negligible mutation, selection, and migration to predict genetic frequencies.

Genetic Diversity Analysis
Evolutionary Processes
Equilibrium Assessments
Popular Tools and Software for Population Genetics Analysis
Ne estimator
Bottleneck
Lamarc

18. Biochemical Genetics: Biochemical genetics is an interdisciplinary field that integrates principles from genetics and biochemistry to explore the relationship between genes and the biochemical processes they influence. This field focuses on understanding how genetic variations affect the structure, function, and metabolism of cellular components, including proteins, carbohydrates, lipids, nucleic acids, and other biomolecules.

Biochemical Pathways
Molecular Functions
Disease Mechanisms
Clinical Applications
Biochemical Testing
Genetic Interpretation

19. Genetic Medicine: Genetic medicine is a specialized field within healthcare focused on the diagnosis, treatment, and management of genetic disorders. It applies principles from medical genetics to address hereditary conditions and utilizes genetic information to guide patient care and therapeutic strategies.

Diagnosis of Genetic Disorders
Treatment and Management
Genetic Counselling
Clinical Applications
Personalized Medicine
Preventive Care
Gene Therapy
Distinctions from Human Genetics
Human Genetics
Medical Genetics
Benefits and Impact
Enhanced Diagnosis
Customized Treatment Plans
Family and Patient Support

20. Genetic Counselling: Genetic counselling is a professional service that provides individuals and families with information and guidance about genetic diseases and their implications. Through genetic counselling, patients can better understand their personal and family health history, assess the risk of genetic disorders, and make informed decisions about their health.

Risk Assessment
Genetic Testing Guidance
Pregnancy Support Services

21. Yoga Practice and Genetic Changes: Yoga practice is increasingly recognized for its impact beyond physical fitness, extending to significant molecular and genetic changes in the body. Recent research highlights that yoga not only promotes physical and mental well-being but also influences gene expression through epigenetic mechanisms.

Molecular-Level Changes in Genes
Mental Health Development

Market Analysis

The study of heritable traits encompasses the examination of genetic characteristics, their properties, and their outcomes. This field includes various aspects such as nuclear hereditary traits, developmental genetic qualities, quantitative genetics, and human hereditary attributes. It integrates multiple disciplines including value formulation, quality design, and change assessment, alongside cytogenetic and genomic imaging. Additionally, it covers genome construction, inheritance patterns, disease associations, nuclear diagnostics, complex genetic disorders, and epistatic interactions. The field also focuses on identifying specific genetic factors linked to diseases, providing significant benefits in the detection, diagnosis, and treatment of conditions such as cancer, cardiovascular diseases, and other hereditary disorders.

According to estimates, the global market for digital pathology will expand from $918.5 million in 2022 to $218.8 million in 2032, at a compound annual growth rate (CAGR) of 9.3%.

The digital pathology and tele pathology market has been analysed across four major geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World.

This report will outline the standard operating procedures for pathology laboratories but will specifically exclude market research related to standard path-lab equipment, such as conventional microscopes and slides. The discussion on connectivity and network issues will be limited to data and information generated by pathology labs in relation to specific diagnoses and will not cover broader hospital-based mHealth concerns. The focus of the report is solely on the diagnostic, research and development (R&D), and educational uses of tele pathology, excluding broader telemedicine applications.

Key Market Drivers
Cost-Effectiveness Drives Expansion
Rising Adoption of Digital Pathology to Enhance Lab Efficiency
Increasing Incidence of Cancer

Target Group
Medical Research Laboratories
Academic Medical Institutes and Universities
Research and Development Companies
Genetics & Genomic Industries

Regional Analysis

Based on advancements in diagnostics, therapeutic developments, and the widespread application of new genetic discoveries, the American market for human genetics stands out as the most advanced. The U.S. benefits from the presence of key industry leaders and a growing focus on genetic traits and their implications for healthcare. This positions America as the leading market for human genetics, driven by increased investments in genetic research and the relevance of genetic information in health insurance.

In Europe, the market for human genetics is primarily driven by the rising prevalence of various genetic disorders and increased governmental support for innovative research methodologies. Germany, in particular, leads the European market due to its strong emphasis on research practices and advancements in genetic science.

The Asia-Pacific region's market growth is fuelled by a heightened interest in studying genetic disorders and the expected rise in the incidence of severe genetic diseases. China, Japan, and India are key contributors to this market, supported by improved research facilities and a growing pool of skilled professionals, including researchers and scientists.

In the Middle East and Africa, while the market for human genetics is relatively small, there is steady progress. This growth is supported by increased funding for healthcare organizations and research projects, despite economic challenges and slower development of research infrastructure, particularly in Africa.

Related Societies

Europe
Clinical Epigenetics Society
The Epigenetics Society
Association of Clinical Cytogeneticists
British Society for Human Genetics
Clinical Genetics Society
Clinical Molecular Genetics Society
Genetics Society
Human Genetics Commission
Austrian Society for Human Genetics
Belgian Society for Human Genetics
Czech Society of Medical Genetics
Danish Society of Medical Genetics
Dutch Association of Clinical Genetics
Finnish Society of Medical Genetics
French Society of Human Genetics
European Society for Medical Oncology
European Oncology Nursing Society
European Association for Cancer Research
European Society of Human Genetics
European Genetics Foundation
European Cytogeneticist Association
European Society of Gene Therapy
Clinical Molecular Genetics Society

USA
American Cancer Society
Haematology/Oncology Pharmacy Association
American Association for Cancer Research
Association of International Cancer Research
International Agency for Research on Cancer
American Society of Human Genetics
National Society of Genetic Counsellors
American College of Medical Genetics
American Board of Genetic Counselling
American Board of Medical Genetics
Nation Coalition for Health Education in Genetics
International Society of Nurses in Genetics
Association of Genetic Technologists
Genetic Society of America

Asia and Middle East
Australian Epigenetics Alliance
Asian Clinical Oncology Society
Asian Oncology Nursing Society
Asian Society of Gynaecologic Oncology
Asian Society for Neuro-Oncology
East Asian Union of Human Genetics Societies
Association of Chinese Geneticists in America
Hong Kong Society of Medical Genetics
Genetics Society of Korea
Korean Society of Human Genetics
Genetics Society of Vietnam
Turkish Association of Medical Genetics
Japan Society of Gene Therapy
American Human Geneticists of Indian Subcontinent Origin
Stem Cell Society of India

Past Conference Report

The 12^th International Congress on Human Genetics and Genetic Diseases was held as a webinar on October 23-24, 2024 in Paris, France. The event brought together academic and professional researchers as well as practitioners dedicated to advancing education in all facets of human genetics.

Conference Series played a crucial role in assembling a diverse panel of key figures from research laboratories, industry, academia, and investment firms to discuss the future of human genetic specializations. The conference aimed to foster the development of innovative ideas in human genetics and facilitate the exchange of concepts among participants, with a focus on exploring future directions in the field.

Looking ahead, the 13^th International Conference on Human Genetics and Genetic Diseases is scheduled to take place in London, UK, on June 12-13, 2025. Conference Series extends its heartfelt gratitude to the organizers, as well as to the many external experts, business representatives, and distinguished professionals who have collaborated with us and provided steadfast support for the conference.

To Collaborate Scientific Professionals around the World

Conference Date June 12-13, 2025

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Supported By

Journal of Molecular and Genetic Medicine Journal of Human Genetics & Embryology Journal of Genetic Syndromes & Gene Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Human Genetics and Genetic Diseases

June 12-13, 2025 London, UK

Innovations in Drug Development for Human Genetic Conditions

Top Human Genetics Meet 2025 | Immunogenetic Summit | Cancer Genomics Conference | Genetic Diseases Meeting | Gene Therapy Event | London | UK | Asia Pacific| Europe | Middle East | USA | Paris

Conference Series Conferences gaining more Readers and Visitors